Drilldown: Medicines
Appearance
Medicines > fda max:
Formulation-dependent
& onset
:
LDL lowering within 2 weeks
or
Postprandial glucose effect within days; HbA1c by 12 weeks 
& onset
:
LDL lowering within 2 weeks
or
Postprandial glucose effect within days; HbA1c by 12 weeks 
Use the filters below to narrow your results.
There are no results for this report.

